Skip to Main


Leading advisory services for the healthcare industry.

Healthcare is ever changing – doctors are embracing technology now more than ever, and as a society, we are living longer and becoming more health-conscious. This growing demand for healthcare opens up a window of opportunities for companies in this market.

Oppenheimer’s Healthcare Investment Banking Group is comprised of dedicated teams focused on the life sciences, medical technology, and healthcare services sectors. We deliver expert-level industry guidance coupled with decades of transaction experience, to assist our clients in achieving their strategic and financial goals.

We have extensive experience serving as both sell side and buy side advisors as well as in underwriting and placing equity and debt offerings for public and privately-held companies. Over the last decade, our healthcare banking professionals have completed financings that raised approximately $30 billion and advised on over 300 merger and acquisition deals valued at approximately $13 billion.*

Our healthcare banking professionals focus on the following sub-sectors:

  • Biotechnology specialty pharmaceuticals and generics
  • Healthcare information technology
  • Healthcare services
  • Medical devices life science tools and diagnostics
*Includes certain transactions completed prior to Oppenheimer’s acquisition in January 2008 of some of CIBC World Markets’ investment banking and capital markets businesses in the U.S., Israel, Europe, and Asia.

Sign up for The Healthcare Intelligencer

A daily newsletter featuring healthcare transactions and sector updates.

*Required field

Michael A. Margolis

Michael A. Margolis, R.Ph.


Co-Head of Healthcare, Head of Healthcare Life Sciences